Funding profile · AI primary care
Clara
A $12 million pre-seed round, announced by the company in May 2026, with no matching SEC Form D found on the public record as of this profile. Here is what is documented and what is not.
Data as of September 25, 2026. Company-reported figures are labeled.
Rounds at a glance
| When | Round | Amount | Investors | Source |
|---|---|---|---|---|
| May 2026 | Pre-seed, oversubscribed | $12,000,000, company-reported | Led by Y Combinator and A.Capital; Liquid 2 Ventures, SV Angel, and named angels including Tim Abbott, Immad Akhund, Vinny Lingham, Jude Gomilla, Kevin Hartz, Brian Pokorny and Dan Burleigh | Company release |
What the filings show
No SEC Form D was found for Clara Health, Inc. or any entity tied to askclara.com in EDGAR company searches for names matching “Clara” and “Clara Health,” including a search restricted to companies located in California and one restricted to companies incorporated in Delaware, as of this research. A separate CIK, 0001606648, is registered to “Clara Health, Inc.” in Seattle, Washington, with a single Form D filed May 5, 2014. That company predates Clara’s 2025 founding by more than a decade and its business address does not match; it is a different entity that happens to share the trademarked name.
Two other entities in EDGAR’s “Clara” name search, CLARA analytics, Inc. and Clara Labs, Inc., are also unrelated: an insurance claims AI company and a scheduling assistant, respectively. A “Clara Series C SPV, a Series of Join Odin Master LP” filed a Form D on September 11, 2026 from a London mailing address; nothing ties it to this company, and Clara has never announced a Series A, let alone a Series C.
Reading the filings
- The $12 million figure is company-reported, not yet confirmed by a filing.A Regulation D issuer generally has 15 days from first sale to file Form D. Clara’s round was announced May 14, 2026; more than four months had passed by this research date with no filing found under the company’s own name.
- The name collision problem is real.“Clara” is a common brand name across fintech, insurance tech and an unrelated 2014 clinical trials startup also called Clara Health. Anyone pulling EDGAR records for this company by name alone risks attributing someone else’s filing to it. None of the Form D filings surfaced in this research were confirmed to belong to the 2025 San Francisco company.
- The corporate structure splits technology from care.Clara’s Terms of Service name Clara Health, Inc. as the operator of the app and five separate professional entities, a PA and PCs for the West, East, Northwest and Midwest regions, as the employers of record for clinicians. A future capital raise could show up under any of these names, or under a parent entity not yet identified.
- The investor list is heavy on angels and platform capital, light on named institutional funds.Outside the two lead investors, Y Combinator and A.Capital, and two named funds, Liquid 2 Ventures and SV Angel, the round’s other participants are listed as individuals. That is typical of a YC-affiliated pre-seed, not a signal of unusual investor composition.
Commercial signals
| Signal | Detail | Source type |
|---|---|---|
| Business model | Cash-pay subscription at $25, $50 and $150 a month; no insurance billing; HSA and FSA eligible. | Independent |
| Scope of care | Company says it treats allergies, hypothyroidism, type 2 diabetes, UTIs and weight management, and will not prescribe controlled substances. | Independent |
| Data pipeline claim | 150,000+ connected hospitals, labs and pharmacies, per the company. Independently flagged as unverified. | Unverified |
| Regulatory hire | Claudia Tucker, formerly SVP of Government Affairs at Teladoc Health, joined as VP of regulatory affairs ahead of a national multi-state launch. | Company-stated |
| Founder capital efficiency | CEO George Favvas says he grew Circle Medical to over $100M in revenue on $12M of primary capital; an independent report puts Circle Medical’s revenue at $64.7M a year. | Differs from independent reporting |
What to watch
- A first Form D under Clara Health, Inc. or a named parent entity, which would confirm the $12M on the public record.
- Any Series A announcement and whether its filed amount matches the press figure.
- Which of the five regional Medical Group entities, or a new one, takes on capital or debt as the company scales its clinician network.
- Whether independent reporting narrows the gap between the company’s Circle Medical revenue claim and Dealroom’s lower figure.
The Clara story on Healthcare DiscoveryHealthcare Discovery
Related companies
Sources
- Public recordEDGAR company search, Form D, companies matching “Clara Health”
- Public recordEDGAR company search, Form D, companies matching “Clara,” State of California
- Public recordEDGAR company search, Form D, companies matching “Clara,” State of Delaware
- CompanyClara launches with $12M pre-seed round, joins Y Combinator
- CompanyClara team page
- CompanyTerms of Service, naming Clara Health, Inc. and affiliated Medical Groups
- IndependentCircle Medical founders launch Clara AI primary care with $12M
- IndependentClara, company and founder listing
- IndependentClara, Y Combinator batch assessment
Compiled from SEC and other public records and published reports as of September 25, 2026. Form D notices report offerings under Regulation D; amounts reflect the filing date. Healthcare Venture Capital Fund holds no position in Clara. This page is not an offer to sell or a recommendation to buy any security.